The impact of crystallization conditions on structure‐based drug design: A case study on the methylene blue/acetylcholinesterase complex

Structure‐based drug design utilizes apoprotein or complex structures retrieved from the PDB. >57% of crystallographic PDB entries were obtained with polyethylene glycols (PEGs) as precipitant and/or as cryoprotectant, but <6% of these report presence of individual ethyleneglycol oligomers. We...

詳細記述

保存先:
書誌詳細
出版年:Protein Sci
主要な著者: Dym, Orly, Song, Wanling, Felder, Clifford, Roth, Esther, Shnyrov, Valery, Ashani, Yacov, Xu, Yechun, Joosten, Robbie P., Weiner, Lev, Sussman, Joel L., Silman, Israel
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2016
主題:
Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941771/
https://ncbi.nlm.nih.gov/pubmed/26990888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pro.2923
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料